Manipulating Life: The Ethics of Emerging Biotechnologies

Manipulating Life: The Ethics of Emerging Biotechnologies

Join Jeffrey Kahn, PhD, MPH, Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, for a two-session lecture series in which you explore the ethics of gene editing. During these live sessions, you will reflect on and discuss the ways in which science and ethics are intertwined.

The combination of reproductive and genetic testing technologies increasingly allow for parents to select traits in what they hope will be their future children. This session will use the first case in the world of the creation of a so-called “savior sibling” to help illustrate the ethical and policy issues arising when new combinations of biotechnologies challenge existing limits.

Jeffrey Kahn, PhD is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, and the Levi Professor of Bioethics and Public Policy. He is also Professor in the Department of Health Policy and Management in the Johns Hopkins University Bloomberg School of Public Health. His research interests include the ethics of research, ethics and public health, and ethics and emerging biomedical technologies. He speaks widely both in the U.S. and abroad, and has published four books and over 125 articles, and is currently co-PI for the Johns Hopkins Center of Excellence in Ethics and Policy Research on Genomics and Infectious Disease (NIH-NHGRI). He is an elected member of the National Academy of Medicine and Fellow of the Hastings Center, and has chaired or served on committees and panels for the National Institutes of Health, the Centers for Disease Control, and the Institute of Medicine/National Academy of Medicine, where he is currently chair of the Board on Health Sciences Policy. His education includes a BA in microbiology (UCLA, 1983), MPH (Johns Hopkins, 1988), and PhD in philosophy (Georgetown, 1989).

Event page: https://events.jhu.edu/form/hahkahn1

Share
Manipulating Life: The Ethics of Emerging Biotechnologies
  • Session 1: Manipulating Life: The Ethics of Emerging Biotechnologies

    Jeffrey Kahn, PhD, MPH - the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the Levi Professor of Bioethics and Public Policy - provides an introduction to the ethics of gene editing. In this first session, Dr. Kahn uses the first case in the world of the c...

  • Session 2: Manipulating Life: The Ethics of Emerging Biotechnologies

    Jeffrey Kahn, PhD, MPH - the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the Levi Professor of Bioethics and Public Policy - provides an introduction to the ethics of gene editing. This session examines some of the implications of a range of potential us...